COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 309
[42] McFarland LV. Systematic review and meta-analysis of
Saccharomyces boulardii in adult patients. World J Gastroenterol.
2010;16(18):2202-2222.
[43] Rodriguez NM, Alarcon P, Gutierrez RM. Clinical outcomes of
parasite cleansing protocols: a retrospective analysis of 658 cases.
Int J Integr Med. 2022;15(3):112-119.
[44] Jenkins M, Chen Y, Spear R. Biomarker improvements following
intestinal parasite treatment in asymptomatic carriers: implications
for subclinical health effects. J Funct Biomech. 2019;8(4):217-225.
[45] Dorsey K, Miller SA, Kemperman RL. Visual identification of
intestinal parasites during therapeutic intervention: a clinical
observation study. J Parasitol Res. 2020;14(2):89-97.
[46] Thompson LJ, Gordon RA, Strasser ET. Safety profile of
botanical antiparasitic compounds: a systematic review of
adverse events. Int J Phytotherapy. 2022;12(4):328-341.
Multi‐System Stress Integration
Spotting patterns with abnormal liver & kidney markers, revisiting
homocysteine, bridging drug3nutrient interactions.
Required Reading:
● Dr. Zachary: p.443 (Drug3Nutrient Depletions), p.4513455
(Patterns & Examples)
Spotting Patterns: Liver & Kidney Markers
Understanding how to spot trends in AST, ALT, and GGT for the
liver, as well as BUN, creatinine, eGFR, electrolytes, and urinary
markers for the kidneys, is key to identifying early dysfunction.
Mild elevations, low-normal values, or gradual shifts can reflect
impaired detoxification, reduced filtration, protein catabolism, or
fluid imbalances. Viewed together, these patterns offer early clues
309
